Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Failure to Thrive in Newborn clinical trials

1 of 1 indexed Failure to Thrive in Newborn trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Failure to Thrive in Newborn: 1 US clinical trial tracked, 1 recruiting.

Failure to Thrive in Newborn is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Columbia University, running 1 of these trials.

Enrollment posture brief

Registry condition failure-to-thrive-in-newborn

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Failure to Thrive in New (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Failure to Thrive in Newborn

Failure to Thrive in Newborn lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Failure to Thrive in Newborn on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Failure to Thrive in Newborn is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Failure to Thrive in Newborn records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification) Dietary supplement
1 trials
Medica Nutrition SolCarb Dietary supplement
1 trials
Nestle Microlipid Dietary supplement
1 trials
Similac Liquid Protein Fortifier Dietary supplement
1 trials
Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid Dietary supplement
1 trials

US sites by state

Facility locations filed on Failure to Thrive in Newborn trials. A trial with sites in several states counts in each.

New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Failure to Thrive in Newborn page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Failure to Thrive in Newborn trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Columbia University sponsors the most Failure to Thrive in Newborn trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Failure to Thrive in Newborn condition card totals 1 registered trials; most-linked intervention Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.